JP2023503722A5 - - Google Patents

Info

Publication number
JP2023503722A5
JP2023503722A5 JP2022556456A JP2022556456A JP2023503722A5 JP 2023503722 A5 JP2023503722 A5 JP 2023503722A5 JP 2022556456 A JP2022556456 A JP 2022556456A JP 2022556456 A JP2022556456 A JP 2022556456A JP 2023503722 A5 JP2023503722 A5 JP 2023503722A5
Authority
JP
Japan
Prior art keywords
unsubstituted
independently
substituted
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022556456A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023503722A (ja
JP7821737B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/062358 external-priority patent/WO2021108662A1/en
Publication of JP2023503722A publication Critical patent/JP2023503722A/ja
Publication of JP2023503722A5 publication Critical patent/JP2023503722A5/ja
Priority to JP2025279753A priority Critical patent/JP2026076156A/ja
Application granted granted Critical
Publication of JP7821737B2 publication Critical patent/JP7821737B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022556456A 2019-11-26 2020-11-25 核酸および半減期モチーフを含む化合物 Active JP7821737B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025279753A JP2026076156A (ja) 2019-11-26 2025-12-24 核酸および半減期モチーフを含む化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962940835P 2019-11-26 2019-11-26
US62/940,835 2019-11-26
PCT/US2020/062358 WO2021108662A1 (en) 2019-11-26 2020-11-25 Compound comprising a nucleic acid and a half-life extension motif

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025279753A Division JP2026076156A (ja) 2019-11-26 2025-12-24 核酸および半減期モチーフを含む化合物

Publications (3)

Publication Number Publication Date
JP2023503722A JP2023503722A (ja) 2023-01-31
JP2023503722A5 true JP2023503722A5 (cg-RX-API-DMAC10.html) 2023-12-04
JP7821737B2 JP7821737B2 (ja) 2026-02-27

Family

ID=74046141

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022556456A Active JP7821737B2 (ja) 2019-11-26 2020-11-25 核酸および半減期モチーフを含む化合物
JP2025279753A Pending JP2026076156A (ja) 2019-11-26 2025-12-24 核酸および半減期モチーフを含む化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025279753A Pending JP2026076156A (ja) 2019-11-26 2025-12-24 核酸および半減期モチーフを含む化合物

Country Status (11)

Country Link
US (1) US20230158150A1 (cg-RX-API-DMAC10.html)
EP (1) EP4065172A1 (cg-RX-API-DMAC10.html)
JP (2) JP7821737B2 (cg-RX-API-DMAC10.html)
KR (2) KR20220150881A (cg-RX-API-DMAC10.html)
CN (2) CN115397471B (cg-RX-API-DMAC10.html)
AU (1) AU2020391218B2 (cg-RX-API-DMAC10.html)
BR (1) BR112022009976A2 (cg-RX-API-DMAC10.html)
CA (1) CA3161669A1 (cg-RX-API-DMAC10.html)
IL (1) IL293341B2 (cg-RX-API-DMAC10.html)
MX (1) MX2022006097A (cg-RX-API-DMAC10.html)
WO (1) WO2021108662A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4398939A1 (en) * 2021-09-10 2024-07-17 Guardian Therapeutics, LLC Fatty acid conjugates of nucleic acids
EP4522742A2 (en) 2022-05-13 2025-03-19 Alnylam Pharmaceuticals, Inc. Single-stranded loop oligonucleotides
WO2024238385A2 (en) 2023-05-12 2024-11-21 Alnylam Pharmaceuticals, Inc. Single-stranded loop oligonucleotides
WO2026163078A1 (en) 2025-01-29 2026-08-06 Novartis Ag Compounds targeting dmpk for the treatment of myotonic dystrophy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586704B1 (fr) * 1985-09-04 1987-12-18 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation et a un groupe chimique activable, leur synthese et leurs applications a titre de nucleases artificielles specifiques de sequences. centre national de la recherche scientifique (cnrs)
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
WO2015006740A2 (en) * 2013-07-11 2015-01-15 Alnylam Pharmaceuticals, Inc. Oligonucleotide-ligand conjugates and process for their preparation
US10588980B2 (en) * 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
EP3603648B1 (en) * 2017-03-29 2025-09-17 Shionogi & Co., Ltd Complex of nucleic acid medicine and multibranched lipid
JP7583712B2 (ja) * 2018-05-30 2024-11-14 ノバルティス アーゲー 脂質修飾された核酸化合物および方法

Similar Documents

Publication Publication Date Title
JP2023503644A5 (cg-RX-API-DMAC10.html)
JP7297676B2 (ja) 新規なカルボニル脂質、および核酸を送達するための脂質ナノ粒子製剤
EP3718572B1 (en) Nucleic acid, composition and conjugate containing nucleic acid, preparation method and use
JP6853193B2 (ja) 核酸複合体
US12577565B2 (en) Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
CN113636947B (zh) 用于递送核酸的新型脂质和脂质纳米颗粒制剂
CN114929282B (zh) 脱唾液酸糖蛋白受体介导的治疗活性缀合物的递送
WO2020233655A1 (zh) 核酸、药物组合物与缀合物及制备方法和用途
WO2020233650A1 (zh) 核酸、药物组合物与缀合物及制备方法和用途
TW202043474A (zh) 一種新化合物及其應用
AU2020282453A1 (en) Nucleic acid, pharmaceutical composition and conjugate, preparation method and use
WO2021037205A1 (zh) 化合物和药物缀合物及其制备方法和用途
AU2002314227B2 (en) Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
EP4541893A1 (en) Sirna molecule for regulating pcsk9 gene activity
TW202604464A (zh) 用於脂質奈米顆粒之galnac脂質化合物
TW593328B (en) Proactive antitumor compounds
US7338805B2 (en) Labeling reagents, methods for synthesizing such reagents and methods for detecting biological molecules
JP2024544975A5 (cg-RX-API-DMAC10.html)
WO2012089945A1 (fr) Dendrimères à terminaison saccharide à visée anti-inflammatoire
US20110130557A1 (en) Intercalating triplexes and duplexes using aryl naphthoimidazol and process for the preparation thereof
JP2024543372A5 (cg-RX-API-DMAC10.html)
JP2001131074A (ja) シアル酸誘導体を有効成分として含む医薬
EP2081944B1 (fr) Nouveaux derives morphiniques
JPH0782291A (ja) 水溶性アンスラサイクリン誘導体
RU2816898C2 (ru) Нуклеиновая кислота, фармацевтическая композиция и конъюгат, способ получения и применение